CLINICAL TRIALS PROFILE FOR VUSION
✉ Email this page to a colleague
All Clinical Trials for VUSION
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00702507 ↗ | Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants | Completed | GlaxoSmithKline | Phase 4 | 2007-05-01 | The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug. |
NCT00702507 ↗ | Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants | Completed | Stiefel, a GSK Company | Phase 4 | 2007-05-01 | The purpose of this study is to determine whether repeated use of 0.25% miconazole nitrate ointment in newborns and infants with a yeast infection in the diaper area causes the yeast to become resistant to the drug. |
NCT01118910 ↗ | Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo | Completed | Image Dermatology P.C. | Early Phase 1 | 2010-04-01 | The purpose of this study is to determine if people with moist, red, patches on their skin in body folds would benefit treatment of those areas with an FDA-approved drug called Vusion. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VUSION
Condition Name
Clinical Trial Locations for VUSION
Trials by Country
Clinical Trial Progress for VUSION
Clinical Trial Phase
Clinical Trial Sponsors for VUSION
Sponsor Name